T1	Participants 230 254	Eligible patients (1439)
T2	Participants 147 164	low-risk patients
T3	Participants 207 216	high risk
T4	Participants 13 25	Wilms' tumor
T5	Participants 1045 1067	279 high-risk patients
T6	Participants 544 567	607 Stage I/FH patients
T7	Participants 715 739	278 Stage II/FH patients
T8	Participants 755 780	275 Stage III/FH patients
